FDA warning letters: how you usually get there, and the realistic recovery path

I’ve had to read — and respond to — enough FDA 483s and warning letters to know they’re rarely about a single misplaced document. Warning letters are the symptom; the cause is usually a broken set of controls working together. To be fair, FDA’s focus is patient safety. In practice this means they look for systemic failures you should have detected earlier under your own QMS. The typical route: inspection → 483 → warning letter FDA inspects. Inspectors document observations on Form FDA 483 (the “